Radical retropubic prostatectomy for prostate cancer with microscopic bladder neck involvement: Survival and prognostic implications

BJU International

Volumn 105, Issue 7, 2010, Pages 946-950

  Villari, Donata ^a   Nesi, Gabriella ^a   Della Melina, Alessandro ^a   Palli, Domenico ^b   Ceroti, Marco ^b   Castigli, Marco ^a   Filocamo, Maria Teresa ^a   Li Marzi, Vincenzo ^a   Nicita, Giulio ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

Author keywords

Bladder; Neoplasm staging; Prostatectomy; Prostatic neoplasms; Survival

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BLADDER NECK; BONE METASTASIS; CANCER INVASION; CANCER RADIOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; GLEASON SCORE; HUMAN; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; QUALITY OF LIFE; RADICAL RETROPUBIC PROSTATECTOMY; SEMINAL VESICLE; URINARY DIVERSION;

ADULT; AGED; AGED, 80 AND OVER; EPIDEMIOLOGIC METHODS; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROSTATECTOMY; PROSTATIC NEOPLASMS; URINARY BLADDER NEOPLASMS;

EID: 77749290037     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2009.08914.x     Document Type: Article

References (26)

1. van den Ouden D, Schroder FH. Management of locally advanced prostate cancer. Staging, natural history, and results of radical surgery. World J Urol 2000 18 : 194 203
2. Ward JF, Slezak JM, Blute ML, Bergstralh EJ, Zincke H. Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome. BJU Int 2005 95 : 751 756
3. Wirth MP, Hakenberg OW, Froehner M. Optimal treatment of locally advanced prostate cancer. World J Urol 2007 35 : 169 176
4. Berglund RK, Jones JS, Ulchaker JC et al. Radical prostatectomy as primary treatment modality for locally advanced prostate cancer: a prospective analysis. Urology 2006 67 : 1253 1256
5. Carver BS, Bianco FJ Scardino PT, Eastham JA. Long-term outcome following radical prostatectomy in men with clinical phase T3 prostate cancer. J Urol 2006 176 : 564 568
6. Yossepowitch O, Sircar K, Scardino PT et al. Bladder neck involvement in pathological phase pT4 radical prostatectomy specimens is not an independent prognostic factor. J Urol 2002 168 : 2011 2015
7. Billis A, Freitas LL, Magna LA, Samara AB, Ferreira U. Prostate cancer with bladder neck involvement: pathologic findings with application of a new practical method for tumor extent evaluation and recurrence-free survival after radical prostatectomy. Int Urol Nephrol 2004 36 : 363 368
8. Dash A, Sanda MG, Yu M, Taylor JM, Fecko A, Rubin MA. Prostate cancer involving the bladder neck: recurrence-free survival and implications for AJCC staging modification. American Joint Committee on Cancer. Urology 2002 60 : 276 280
9. Poulos CK, Koch MO, Eble JN, Daggy JK, Cheng L. Bladder neck invasion is an independent predictor of prostate-specific antigen recurrence. Cancer 2004 101 : 1563 1568
10. Rodriguez-Covarrubias F, Larré S, Dahan M et al. Invasion of bladder neck after radical prostatectomy: one definition for different outcomes. Prostate Cancer Prostatic Dis 2008 11 : 294 297
11. Buschemeyer WC, Hamilton RJ, Aronson WJ et al. Is a positive bladder neck margin truly a T4 lesion in the prostate specific antigen era? Results from the SEARCH database. J Urol 2008 179 : 124 129
12. Johnstone PA, Ward KC, Goodman M, Assikis V, Petros JA. Radical prostatectomy for clinical T4 prostate cancer. Cancer 2006 106 : 2603 2609
13. American Joint Committee on Cancer. Prostate (sarcomas and transitional cell carcinomas are not included). AJCC Cancer Staging Manual, 6th edn. New York : Springer-Verlag, 2002 : 309 316
14. McNeal JE, Villers AA, Redwine EA, Freiha FS, Stamey TA. Histological differentiation, cancer volume, and pelvic lymph node metastasis in adenocarcinoma of the prostate. Cancer 1990 66 : 1225 1233
15. Epstein JI, Allsbrook WC Amin MB, Egevad LL the ISUP Grading Committee. The International Society of Urological Pathology (ISUP) Consensus Conference on Gleason grading of prostatic carcinoma. Am J Surg Pathol 2005 29 : 1228 1242
16. Kattan MW, Wheeler TM, Scardino PT. Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer. J Clin Oncol 1999 17 : 1499 1507
17. Heidenreich A, Aus G, Abbou CC et al. EAU guidelines on prostate cancer. Eur Urol 2008 53 : 68 80
18. Yossepowitch O, Eggener SE, Carver BS, Bianco FJ, Scardino PT, Eastham JA. Secondary therapy, metastatic progression, and cancer-specific mortality in men with clinically high-risk prostate cancer treated with radical prostatectomy. Eur Urol 2008 53 : 950 9
19. Sakr WA, Grignon DJ. Prostate. Practice parameters, pathologic staging, and handling radical prostatectomy specimens. Urol Clin North Am 1999 26 : 453 463
20. Bostwick DG, Foster CS. Predictive factors in prostate cancer: current concepts from the 1999 College of American Pathologists Conference on Solid Tumor Prognostic Factors and the 1999 World Health Organization Second International Consultation on Prostate Cancer. Semin Urol Oncol 1999 17 : 222 272
21. Montironi R, van der Kwast T, Boccon-Gibod L, Bono AV, Boccon-Gibod L. Handling and pathology reporting of radical prostatectomy specimens. Eur Urol 2003 44 : 626 636 (Pubitemid 37542919)
22. Aydin H, Tsuzuki T, Hernandez D, Walsh PC, Partin AW, Epstein JI. Positive proximal (bladder neck) margin at radical prostatectomy confers greater risk of biochemical progression. Urology 2004 64 : 551 555
23. Bolla M, Collette L, Blank L et al. Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial. Lancet 2002 360 : 103 106
24. Pilepich MV, Winter K, Lawton CA et al. Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma: long-term results of phase III RTOG 85-31. Int J Radiat Oncol Biol Phys 2005 61 : 1285 1290 (Pubitemid 40470408)
25. Daneshmand S, Quek ML, Stein JP et al. Prognosis of patients with lymph node positive prostate cancer following radical prostatectomy: long term results. J Urol 2004 172 : 2252 2255
26. Cheng L, Zincke H, Blute ML, Bergstralh EJ, Scherer B, Bostwick DG. Risk of prostate carcinoma death in patients with lymph node metastasis. Cancer 2001 91 : 66 73